Dobbs Ferry, NY, United States of America

Guido Pollevick


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Guido Pollevick

Introduction

Guido Pollevick is an accomplished inventor based in Dobbs Ferry, NY (US). He has made significant contributions to the field of medical research, particularly in understanding genetic mutations associated with cardiac conditions. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of serious health issues.

Latest Patents

Pollevick's latest patents focus on the CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death. These patents disclose previously unknown mutations of the CACNA1C and CACNB2b genes, which are involved in ion channel disruptions. The mutations are utilized to diagnose and screen for shorter than normal QT interval and ST segment elevation syndrome. This provides modalities for diagnosing syncope and/or sudden cardiac death and/or predicting susceptibility to these conditions. Additionally, nucleic acid probes are provided that selectively hybridize to the mutant nucleic acids, along with antibodies that selectively bind to the mutant polypeptides. The mutations are also used to screen for compounds that may treat the symptoms associated with these genetic disruptions.

Career Highlights

Throughout his career, Guido Pollevick has worked with notable organizations, including the Masonic Medical Research Laboratory. His research has contributed to a deeper understanding of cardiac health and the genetic factors that influence it.

Collaborations

One of his prominent collaborators is Charles Antzelevitch, a respected figure in the field of cardiac research. Their partnership has likely enhanced the quality and impact of their research endeavors.

Conclusion

Guido Pollevick's innovative work in the realm of genetic mutations related to cardiac conditions showcases his dedication to advancing medical science. His patents and research have the potential to save lives and improve health outcomes for individuals at risk of sudden cardiac events.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…